Repetitive dengue outbreaks in East Africa: A proposed phased mitigation approach may reduce its impact

被引:25
作者
Baba, Marycelin [1 ,2 ]
Villinger, Jandouwe [1 ]
Masiga, Daniel K. [1 ]
机构
[1] Int Ctr Insect Physiol & Ecol Icipe, Martin Luscher Emerging Infect Dis Lab ML EID, POB 30772, Nairobi, Kenya
[2] Univ Maiduguri, Dept Med Lab Sci, PMB 1069, Maiduguri, Nigeria
关键词
RIFT-VALLEY FEVER; NEUTRALIZING ANTIBODIES; CLIMATE VARIABILITY; VECTOR COMPETENCE; YELLOW-FEVER; VIRUS; SEROPREVALENCE; EPIDEMIOLOGY; SURVEILLANCE; INFECTIONS;
D O I
10.1002/rmv.1877
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dengue outbreaks have persistently occurred in eastern African countries for several decades. We assessed each outbreak to identify risk factors and propose a framework for prevention and impact mitigation. Seven out of ten countries in eastern Africa and three islands in the Indian Ocean have experienced dengue outbreaks between 1823 and 2014. Major risk factors associated with past dengue outbreaks include climate, virus and vector genetics and human practices. Appropriate use of dengue diagnostic tools and their interpretation are necessary for both outbreak investigations and sero-epidemiological studies. Serosurvey findings during inter-epidemic periods have not been adequately utilised to prevent re-occurrence of dengue outbreaks. Local weather variables may be used to predict dengue outbreaks, while entomological surveillance can complement other disease-mitigation efforts during outbreaks and identify risk-prone areas during inter-epidemic periods. The limitations of past dengue outbreak responses and the enormous socio-economic impacts of the disease on human health are highlighted. Its repeated occurrence in East Africa refutes previous observations that susceptibility may depend on race. Alternate hypotheses on heterotypic protection among flaviviruses may not be applied to all ecologies. Prevention and mitigation of severe dengue outbreaks should necessarily consider the diverse factors associated with their occurrence. Implementation of phased dengue mitigation activities can enforce timely and judicious use of scarce resources, promote environmental sanitation, and drive behavioural change, hygienic practices and community-based vector control. Understanding dengue epidemiology and clinical symptoms, as determined by its evolution, are significant to preventing future dengue epidemics. Copyright (c) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:183 / 196
页数:14
相关论文
共 104 条
[91]   Human dengue antibodies against structural and nonstructural proteins [J].
Valdés, K ;
Alvarez, M ;
Pupo, M ;
Vázquez, S ;
Rodríguez, R ;
Guzmán, MG .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (05) :856-857
[92]  
Van Kleef E., 2010, TropIKAnet, V2010, P1
[93]  
Van Rooyen C, 1948, VIRUS DISEASES OF MA
[94]   The Human Antibody Response to Dengue Virus Infection [J].
Wahala, Wahala M. P. B. ;
de Silva, Aravinda M. .
VIRUSES-BASEL, 2011, 3 (12) :2374-2395
[95]   Present and future arboviral threats [J].
Weaver, Scott C. ;
Reisen, William K. .
ANTIVIRAL RESEARCH, 2010, 85 (02) :328-345
[96]  
WHO epidemic and pandemic alert and response, 2014, WHO EPIDEMIC PANDEMI
[97]  
World Health Organization, 2009, WHO GUID ID EC CONS
[98]  
World Health Organization, 2013, GLOB AL RESP YELL FE
[99]  
World Health Organization, 2011, HUM HLTH ACT HORN AF
[100]  
World Health Organization, 2013, YELL FEV SUD UPD GLO